GlassScriptPhysician profile
Jessica O Yu
NPI 1669671848
$90,407.78
in general payments reported to CMS, 2019-2025
18 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what 88% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
See the full distribution for Corneal and Contact Management
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $22K · 2021: $35K · 2022: $6,958 · 2023: $6,567 · 2024: $766 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,900 · Food and Beverage: $2,579 · Consulting Fee: $1,890 · Travel and Lodging: $1,193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,900.00 |
| Food and Beverage | $2,578.69 |
| Consulting Fee | $1,890.00 |
| Travel and Lodging | $1,193.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $49,488.98 | 2019-2021 | |
| Alcon Vision LLC | $27,222.71 | 2019-2025 | Precision7, Precision 1, Total30 |
| Bausch & Lomb Americas INC. | $9,827.51 | 2022-2025 | Infuse, Xiidra, Miebo |
| Johnson & Johnson Vision Care, INC. | $2,254.54 | 2019-2025 | Acuvue |
| Oyster Point Pharma, INC. | $362.92 | 2022-2023 | Tyrvaya |
| Coopervision INC. | $288.35 | 2020-2025 | Misight Contact Lens, Paragon Crt, Clariti Contact Lens |
| Allergan, INC. | $249.09 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $227.27 | 2024-2025 | Xdemvy |
| Sight Sciences, INC. | $152.48 | 2019-2022 | |
| Glaukos Corporation | $110.30 | 2025 | Photrexa Viscous and Photrexa |
| Visioneering Technologies, INC. | $59.94 | 2019-2020 | |
| Synergeyes, INC. | $50.00 | 2020 | |
| Novartis Pharmaceuticals Corporation | $24.50 | 2019 | |
| Abb Con-Cise Optical Group LLC | $23.20 | 2025 | Contact Lens |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $18.83 | 2025 | Oxervate |
| Shire North American Group INC | $16.74 | 2019 | |
| Alcon Research LLC | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.